unanswered questions and conundrums with frontline nsclc
Published 4 years ago • 6 plays • Length 13:11Download video MP4
Download video MP3
Similar videos
-
1:05
dr. chiang on unanswered questions with immunotherapy in nsclc
-
3:14
the key unanswered question in lung cancer?
-
1:19
unanswered questions with the role of tmb in nsclc
-
5:32
experts discuss unanswered questions in nsclc
-
1:40
unanswered questions in breast cancer
-
56:35
the genealogy of the milky way and the search for the missing dark matter ▸ chalk talk by lina necib
-
4:11
‘dark dna’ is the latest mystery in the world of genetics… but what is it?
-
3:46
understanding immunotherapy for lung cancer
-
1:48
unanswered questions in lung cancer immunotherapy
-
1:42
dr. vokes discusses unanswered questions from the pacific trial in nsclc
-
6:56
what testing should be done before frontline therapy for advanced nsclc?
-
8:45
nivolumab ipilimumab vs platinum-doublet chemotherapy as first-line treatment for advanced nsclc
-
1:00
dr. konduri addresses unanswered questions in nsclc
-
6:51
progression in alk nsclc after frontline therapy
-
2:07
checkmate 816: addressing unanswered questions on surgical outcomes following neoadjuvant chemo-io
-
6:23
frontline chemo and tki combination in egfr nsclc
-
4:37
frontline therapy approaches for small cell lung cancer
-
1:48
dr. mark kris on immunotherapy and frontline options for patients with nsclc
-
4:26
lung cancer treatment: what is immunotherapy?
-
7:20
small-cell lung cancer: the impower133 and caspian trials
-
7:52
local therapy for nsclc patients after frontline therapy